Article
A potential patient stratification biomarker for Parkinso’s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
2023-04-12
Abstract excerpt
Parkinso’s disease (PD) is a common neurodegenerative movement disorder and leucine-rich repeat kinase 2 (LRRK2) is a promising therapeutic target for disease intervention. However, the ability to stratify patients who will benefit from such treatment modalities based on shared etiology is critical for the success of disease-modifying therapies. Ciliary and centrosomal alterations are commonly associated with path...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- da181a79-1490-51bb-9a87-1bb6cf329af4
- DOI
- 10.1101/2023.04.11.536367
